Qin, E., and N. Guilz. “Using CRISPR-Cas9 In Human Fetuses to Prevent Trisomy 16 and Trisomy 22 Induced Miscarriages”. Journal of Student Research, vol. 11, no. 4, Nov. 2022, doi:10.47611/jsrhs.v11i4.3859.